Online Only Articles

The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma

Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Pamplona
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain
Hospital 12 de Octubre, Madrid, Spain
Hospital 12 de Octubre, Madrid, Spain
Hospital Universitario de Salamanca, Instituto de Investigaion Biomedica de Salamanca, IBMCC (USAL-CSIC), Spain
Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Pamplona
Vol. 100 No. 2 (2015): February, 2015 https://doi.org/10.3324/haematol.2014.115162